Gilead’s Coronavirus Drug Trial Slowed Due to Lack of Eligible Recruits

A trial of Gilead’s coronavirus drug has been slowed, as eligible recruits prove hard to come by

The trials, aimed at testing more than 700 patients infected with the Wuhan coronavirus, have succeeded in recruiting fewer than 200 people after 10 days.

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

WSJ /  🏆 98. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

New Zealand PM Ardern sees 2020 growth slowing to 2-2.5% due to coronavirusNew Zealand Prime Minister Jacinda Ardern said on Monday that the country's...
Les mer »

Japan to start trials using HIV treatment for coronavirus: SugaJapan is aiming to start trials soon using an HIV treatment for the coronavirus,...
Les mer »

Japan to start trials using HIV treatment for coronavirus - SugaJapan is aiming to start trials soon using an HIV treatment for the coronavirus,...
Les mer »

Japan plans HIV drug trials for coronavirus, cruise ship evacuations continueJapan plans HIV drug trials for coronavirus, cruise ship evacuations continue by sakmurakami juminism For the latest developments around the new coronavirus outbreak, follow our liveblog:
Les mer »

Coronavirus infections slow in China as Apple warns of iPhone shortagesThe number of new coronavirus infections in mainland China fell below 2,000 on T...
Les mer »

Global goods trade already slow; coronavirus will likely make it worse, WTO saysGlobal trade in goods will likely be weak in coming months as disruptions from the coronavirus outbreak stanch the movement of international commerce.
Les mer »